Reverse hybridization StripAssay detection of β-thalassemia mutations in northeast Egypt

Hematology

Volumn 15, Issue 3, 2010, Pages 182-186

  Soliman, Othman E ^a   Yahia, Sohier ^a   Shouma, Amany ^a   Shafiek, Hala K ^a   Fouda, Ashraf E ^a   Azzam, Hanan ^a   Abousamra, Nashwa K ^a   Mahfouz, Rabab ^a   Goda, Enas F ^a   El Sharawy, Solafa A ^a  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

Author keywords

Beta Thalassemias; Egyptian children; Reverse hybridization StriPassay

Indexed keywords

BETA GLOBIN; GENOMIC DNA; DIAGNOSTIC KIT;

ACCURACY; ARTICLE; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EGYPT; FEMALE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN CELL; MALE; MUTATIONAL ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCHOOL CHILD; ADOLESCENT; BETA-THALASSEMIA; DIAGNOSTIC KIT; GENETICS; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROCEDURES;

ADOLESCENT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EGYPT; FEMALE; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; REAGENT KITS, DIAGNOSTIC;

EID: 77953602832     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453310X12583347010214     Document Type: Article

References (32)

1. Weatherall DJ, Clegg JB. The thalassaemia syndromes, 4th edn. Oxford: Blackwell Science, 2001.
2. Habib Z, Book JA. Thalassemia in the Egyptian population. Hereditas 1982; 95: 149-158.
3. Hashem N. Thalassemia syndromes and other hemoglobinopathies. Proceedings of the First International Conference, Vol.1. Cairo, Egypt. 1978; 54.
4. El-Beshlawy A, Kaddah N, Hafwz M, Abdel Azim M, Omar N. Genetic study in Egyptian thalassemic patients. Proc EMS ANN Cong 1994. www.informaworld.com/ index/9019304-58.pdf
5. Vrettou C, Traeger-Synodinos J, Tzetis M, Malamis G, Kanavakis E. Rapid screening of multiple globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem 2003; 49: 5769-5776.
6. Olivieri NF. The b-thalassemias. N Eng J Med 1999; 341: 99-109.
7. Flint J, Harding R, Boyce AJ, Cleeg JB. The population genetics of the haemoglobinopathies. Bailliere's Clin Haematol 1998; 11: 1-51.
8. Baysal E, Carver MF. The beta- and delta-thalassemia repository (eighth edition). Hemoglobin 1995; 19: 213-236.
9. Bhavnani M, Brozovic M, Old JM et al. Guidelines for the fetal diagnosis of globin gene disorders. Globin Gene Disorder Working Party of the BCSH General Haematology Task Force. J Clin Pathol 1994; 47: 199-204.
10. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest 2007; 67: 71-86.
11. Najmabadi H, Teimourian S, Khatibi T et al. Amplification refractory mutation system (ARMS) and reverse hybridization in the detection of beta-thalassemia mutations. Arch Inn Med 2001; 4: 165-170.
12. Tuzmen S, Schechter AN. Genetic diseases of hemoglobin: diagnostic methods for elucidating beta-thalassemia mutations. Blood Rev 2001; 15: 19-29.
13. Basak AN. The molecular pathology of beta-thalassemia in Turkey: the Bogäziçi university experience. Hemoglobin 2007; 31: 233-241.
14. Hussein G, Fawzy M, Serafi TE et al. Rapid detection of beta- Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control. Hemoglobin 2007; 31: 49-62.
15. Novelletto A, HafezM, Deidda G et al. Molecular characterization of beta-thalassemia mutations in Egypt. Hum Genet 1990; 85: 272-274.
16. Waye JS, Borys S, Eng B et al. Spectrum of P-thalassemia mutations in Egypt. Hemoglobin 1999; 23: 255-261.
17. Omar A, Abdel Karim E, Gendy WE, Marzouk I, Wagdy M. Molecular basis of beta-thalassemia in Alexandria. Egypt J Immunol 2005; 12: 15-24.
18. El-Gawhary S, El-Shafie S, Niazi M, Aziz M, El-Beshlawy A. Study of beta-thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian thalassemia patients. Hemoglobin 2007; 31: 63-69.
19. Kyriacou K, Al Quobaili F, Pavlou E, Christopoulos G, Ioannou P, Kleanthous M. Molecular characterization of B-thalassemias in Syria. Hemoglobin 2000; 24: 1-13.
20. Waye JS, Patterson M, Eng B, Scully MF. Beta-thalassemia intermedia in a Lebanese child due to homozygosity for the 288 (CRT) mutation. Hemoglobin 1994; 18: 383-388.
21. El-Hazmi MA, Warsy AS, Al-Swailem AR. The frequency of 14 beta-thalassemia mutations in the Arab populations. Hemoglobin 1995; 19: 353-360.
22. Zahed L, Talhouk R, Saleh M, Abou-Jaoudeh R, Fisher C, Old J. The spectrum of beta-thalassaemia mutations in the Lebanon. Hum Hered 1997; 47: 241-249.
23. Chibani J, Vidaud M, Duquesnoy P et al. The peculiar spectrum of beta-thalassemia genes in Tunisia. Hum Genet 1988; 78: 190-192.
24. Keser I, Sanlioglu AD, Manguoglu E et al. Molecular analysis of beta-thalassemia and sickle cell anemia in Antalya. Acta Haematol 2004; 111: 205-210.
25. Baysal E, Indrak K, Bozkurt G et al. The b-thalassemia mutations in the population of Cyprus. Br J Haematol 1992; 81: 607-609.
26. Huisman TH. Beta-thalassemia in four Mediterranean countries: an editorial commentary. Hemoglobin 1990; 14: 35-39.
27. Tadmouri G. Deniz: the electronic database for b-thalassaemia mutations in the Arab world. Saudi Med J 2003; 24: 1192-1198.
28. Al-Allawi NA, Jubrael JM, Hughson M. Molecular characterization of beta-thalassemia in the Dohuk region of Iraq. Hemoglobin 2006; 30: 479-486.
29. Puehringer H, Najmabadi H, Law HY et al. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common alpha-thalassemia point mutations and deletions. Clin Chem Lab Med 2007; 45: 605-610.
30. Delague V, Kriegshäuser G, Oberkanins C, Mégarbané A. Reverse hybridization vs. DNA sequencing in the molecular diagnosis of Familial Mediterranean fever. Genet Test 2004; 8: 65-68.
31. Panigrahi I, Agarwal S. Genetic determinants of phenotype in beta-thalassemia. Hematology 2008; 13: 247-252.
32. Thein SL. Genetic modifiers of beta-thalassemia. Haematologica 2005; 90: 649-660.